Targeting Treg Cells In Situ: Emerging Expansion Strategies for (CD4+CD25+) Regulatory T Cells

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 10, 2009, Pages 1239-1243

  Shatry, Alwi ^a   Chirinos, Jackeline ^a   Gorin, Michael A ^a   Jones, Monica ^a   Levy, Robert B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

CD4+CD25+; Expansion strategies; Immune regulation; In situ manipulation; Marrow allograft resistance; Treg cells

Indexed keywords

ALLOANTIGEN; CYTOKINE ANTIBODY; HLA ANTIGEN CLASS 2; INTERLEUKIN 2;

ALLERGY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELLULAR IMMUNITY; DENDRITIC CELL; DONOR; ENGRAFTMENT; EPIGENETICS; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

ANIMALS; ANTIBODIES; ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; CELL PROLIFERATION; HUMANS; INTERLEUKIN-2; NEOPLASMS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION IMMUNOLOGY;

EID: 69749097294     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.06.009     Document Type: Review

References (46)

1. Godfrey W.R., Ge Y.G., Spoden D.J., et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104 (2004) 453-461
2. Levings M.K., Sangregorio R., and Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193 (2001) 1295-1302
3. Hoffmann P., Eder R., Kunz-Schughart L.A., et al. Large-scale in vitro expansion of polyclonal human CD4 + CD25high regulatory T cells. Blood 104 (2004) 895-903
4. Taylor P.A., Lees C.J., and Blazar B.R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99 (2002) 3493-3499
5. Turnquist H.R., Raimondi G., Zahorchak A.F., et al. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4 + T cells, but enrich for antigen-specific Foxp3 + T regulatory cells and promote organ transplant tolerance. J Immunol 178 (2007) 7018-7031
6. Putnam A.L., Brusko T.M., Lee M.R., et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58 (2009) 652-662
7. Earle K.E., Tang Q., Zhou X., et al. In vitro expanded human CD4 + CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 115 (2005) 3-9
8. Tang Q., Henriksen K.J., Bi M., et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 (2004) 1455-1465
9. Cohen J.L., Trenado A., Vasey D., et al. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 196 (2002) 401-406
10. Yamazaki S., Iyoda T., Tarbell K., et al. Direct expansion of functional CD25 + CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198 (2003) 235-247
11. Joffre O., Santolaria T., Calise D., et al. Prevention of acute and chronic allograft rejection with CD4 + CD25 + Foxp3+ regulatory T lymphocytes. Nat Med 14 (2008) 88-92
12. Chai J.G., Coe D., Chen D., et al. In vitro expansion improves in vivo regulation by CD4 + CD25+ regulatory T cells. J Immunol 180 (2008) 858-869
13. Sega E.I., Leveson-Gower D., Nguyen V.H., et al. Functional comparison of freshly isolated and ex-vivo expanded CD4 + CD25 + Foxp3+ regulatory T cells in suppressing murine acute GvHD. ASH Annu Meet Abstrs 112 (2008) 812
14. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
15. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
16. Hoffmann P., Eder R., Boeld T.J., et al. Only the CD45RA+ subpopulation of CD4 + CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108 (2006) 4260-4267
17. Hoffmann P., Boeld T.J., Eder R., et al. Loss of FOXP3 expression in natural human CD4 + CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 39 (2009) 1088-1097
18. Kim H.P., and Leonard W.J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204 (2007) 1543-1551
19. Barao I., Hanash A.M., Hallett W., et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4 + CD25+ regulatory T cells. Proc Natl Acad Sci USA 103 (2006) 5460-5465
20. Barnett B., Kryczek I., Cheng P., et al. Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am J Reprod Immunol 54 (2005) 369-377
21. Dannull J., Su Z., Rizzieri D., et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115 (2005) 3623-3633
22. Mahnke K., Schonfeld K., Fondel S., et al. Depletion of CD4 + CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int J Cancer 120 (2007) 2723-2733
23. Litzinger M.T., Fernando R., Curiel T.J., et al. IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood 110 (2007) 3192-3201
24. Kim J.M., Rasmussen J.P., and Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8 (2007) 191-197
25. Lin C.H., and Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 33 (2003) 626-638
26. Beyersdorf N., Ding X., Blank G., et al. Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody. Blood 112 (2008) 4328-4336
27. Lan Y.Y., Wang Z., Raimondi G., et al. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3 + CD4 + T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 177 (2006) 5868-5877
28. Battaglia M., Stabilini A., and Roncarolo M.G. Rapamycin selectively expands CD4 + CD25 + FoxP3+ regulatory T cells. Blood 105 (2005) 4743-4748
29. Kavanagh B., O'Brien S., Lee D., et al. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4 + T cells in a dose-dependent fashion. Blood 112 (2008) 1175-1183
30. Kessel A., Ammuri H., Peri R., et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 179 (2007) 5571-5575
31. Ephrem A., Chamat S., Miquel C., et al. Expansion of CD4 + CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 111 (2008) 715-722
32. Boyman O., Kovar M., Rubinstein M.P., et al. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311 (2006) 1924-1927
33. Webster K.E., Walters S., Kohler R.E., et al. In vivo expansion of T reg cells with IL-2 -mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 206 (2009) 751-760
34. Shatry A., and Levy R.B. In situ activation and expansion of host Tregs: a new approach to enhance donor chimerism and stable engraftment in MHC-matched allogeneic HCT. Biol Blood Marrow Transplant 15 (2009) 785-794
35. Bayer A.L., Jones M., Chirinos J., et al. Host CD4 + CD25 + T cells can expand and comprise a major component of the Treg compartment after experimental HCT. Blood 113 (2009) 733-743
36. Taylor P.A., Noelle R.J., and Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193 (2001) 1311-1317
37. Verbinnen B., Billiau A.D., Vermeiren J., et al. Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. J Immunol 181 (2008) 1034-1042
38. Wilson M.S., Pesce J.T., Ramalingam T.R., et al. Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J Immunol 181 (2008) 6942-6954
39. Ahmadzadeh M., and Rosenberg S.A. IL-2 administration increases CD4 + CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood 107 (2006) 2409-2414
40. Zhang H., Chua K.S., Guimond M., et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4 + CD25+ regulatory T cells. Nat Med 11 (2005) 1238-1243
41. Tang Q., Adams J.Y., Penaranda C., et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28 (2008) 687-697
42. Zorn E., Nelson E.A., Mohseni M., et al. IL-2 regulates FOXP3 expression in human CD4 + CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108 (2006) 1571-1579
43. Zorn E., Mohseni M., Kim H., et al. Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15 (2009) 382-388
44. Elpek K.G., Yolcu E.S., Franke D.D., et al. Ex vivo expansion of CD4 + CD25 + FoxP3 + T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 179 (2007) 7295-7304
45. Pillai A.B., George T.I., Dutt S., et al. Host natural killer T cells induce an IL-4 dependent expansion of donor CD4 + CD25 + Foxp3 + Tregs that protects against graft-versus-host disease. Blood 113 (2009) 4458-4467
46. Robertson S.A., Guerin L.R., Bromfield J.J., et al. Seminal fluid drives expansion of the CD4 + CD25 + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 80 (2009) 1036-1045